Phreesia, Inc.'s (NYSE:PHR) P/S Is Still On The Mark Following 43% Share Price Bounce
Phreesia, Inc.'s (NYSE:PHR) P/S Is Still On The Mark Following 43% Share Price Bounce
Phreesia, Inc. (NYSE:PHR) shares have had a really impressive month, gaining 43% after a shaky period beforehand. Not all shareholders will be feeling jubilant, since the share price is still down a very disappointing 32% in the last twelve months.
Phreesia, Inc.(紐約證券交易所代碼:PHR)的股價經歷了非常令人印象深刻的一個月,在經歷了動盪時期之後上漲了43%。並非所有股東都會感到歡欣鼓舞,因爲在過去十二個月中,股價仍下跌了令人失望的32%。
Since its price has surged higher, you could be forgiven for thinking Phreesia is a stock not worth researching with a price-to-sales ratios (or "P/S") of 3.7x, considering almost half the companies in the United States' Healthcare Services industry have P/S ratios below 2x. Although, it's not wise to just take the P/S at face value as there may be an explanation why it's as high as it is.
由於其價格飆升,考慮到美國醫療保健服務行業中將近一半的公司的市盈率低於2倍,你認爲Phreesia是一隻不值得研究的股票,其市售率(或 “市盈率”)爲3.7倍,這是可以原諒的。但是,僅按面值計算市盈率是不明智的,因爲可以解釋爲什麼市盈率如此之高。
See our latest analysis for Phreesia
查看我們對Phreesia的最新分析
![](https://newsfile.futunn.com/public/NN-PersistNewsContentImage/7781/20231218/0-99b646fc5c5beadca39d0391275a73fe-0-dcc914c9ae07868615a61cdc9d348d6e.png/big)
NYSE:PHR Price to Sales Ratio vs Industry December 18th 2023
紐約證券交易所:PHR 價格與銷售比率與行業對比 2023 年 12 月 18 日
What Does Phreesia's P/S Mean For Shareholders?
Phreesia的市盈率對股東意味着什麼?
With revenue growth that's superior to most other companies of late, Phreesia has been doing relatively well. The P/S is probably high because investors think this strong revenue performance will continue. You'd really hope so, otherwise you're paying a pretty hefty price for no particular reason.
由於最近收入增長優於大多數其他公司,Phreesia的表現相對較好。市盈率之所以很高,可能是因爲投資者認爲這種強勁的收入表現將繼續下去。你真的希望如此,否則你將無緣無故地付出相當高的代價。
Keen to find out how analysts think Phreesia's future stacks up against the industry? In that case, our free report is a great place to start.
想了解分析師如何看待Phreesia的未來與該行業背道而馳嗎?在這種情況下,我們的免費報告是一個不錯的起點。
What Are Revenue Growth Metrics Telling Us About The High P/S?
收入增長指標告訴我們關於高市盈率的哪些信息?
In order to justify its P/S ratio, Phreesia would need to produce impressive growth in excess of the industry.
爲了證明其市盈率是合理的,Phreesia需要實現超過該行業的驚人增長。
Taking a look back first, we see that the company grew revenue by an impressive 29% last year. The strong recent performance means it was also able to grow revenue by 142% in total over the last three years. Therefore, it's fair to say the revenue growth recently has been superb for the company.
首先回顧一下,我們發現該公司去年的收入增長了令人印象深刻的29%。最近的強勁表現意味着在過去三年中,它的總收入也增長了142%。因此,可以公平地說,該公司最近的收入增長非常好。
Turning to the outlook, the next three years should generate growth of 19% each year as estimated by the analysts watching the company. That's shaping up to be materially higher than the 13% each year growth forecast for the broader industry.
談到前景,根據關注該公司的分析師的估計,未來三年每年將實現19%的增長。這將大大高於整個行業每年13%的增長預期。
With this information, we can see why Phreesia is trading at such a high P/S compared to the industry. Apparently shareholders aren't keen to offload something that is potentially eyeing a more prosperous future.
有了這些信息,我們可以明白爲什麼與行業相比,Phreesia的市盈率如此之高。顯然,股東們並不熱衷於拋售可能展望更繁榮未來的東西。
The Key Takeaway
關鍵要點
The large bounce in Phreesia's shares has lifted the company's P/S handsomely. Typically, we'd caution against reading too much into price-to-sales ratios when settling on investment decisions, though it can reveal plenty about what other market participants think about the company.
Phreesia股價的大幅反彈極大地提高了該公司的市盈率。通常,在做出投資決策時,我們會謹慎行事,不要過多地解讀市銷比率,儘管這可以充分揭示其他市場參與者對公司的看法。
We've established that Phreesia maintains its high P/S on the strength of its forecasted revenue growth being higher than the the rest of the Healthcare Services industry, as expected. At this stage investors feel the potential for a deterioration in revenues is quite remote, justifying the elevated P/S ratio. Unless the analysts have really missed the mark, these strong revenue forecasts should keep the share price buoyant.
我們已經確定,Phreesia之所以能保持較高的市盈率,是因爲其預測的收入增長高於醫療保健服務行業的其他行業。在現階段,投資者認爲收入惡化的可能性非常小,這爲市盈率上升辯護。除非分析師真的沒有達到目標,否則這些強勁的收入預測應該會使股價保持活力。
We don't want to rain on the parade too much, but we did also find 4 warning signs for Phreesia that you need to be mindful of.
我們不想在遊行隊伍中下太多雨,但我們也發現了 4 個需要注意的 Phreesia 警告信號。
If these risks are making you reconsider your opinion on Phreesia, explore our interactive list of high quality stocks to get an idea of what else is out there.
如果這些風險使您重新考慮對Phreesia的看法,請瀏覽我們的優質股票互動清單,以了解還有什麼。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。